tiprankstipranks
Bausch Health sees FY25 revenue $9.90B-$10.15B, consensus $9.89B
PremiumThe FlyBausch Health sees FY25 revenue $9.90B-$10.15B, consensus $9.89B
2d ago
Closing Bell Movers: Carvana down 8% on earnings, Palantir extends decline
Premium
The Fly
Closing Bell Movers: Carvana down 8% on earnings, Palantir extends decline
2d ago
Bausch Health reports Q4 adjusted EBITDA $935M vs. $869M last year
Premium
The Fly
Bausch Health reports Q4 adjusted EBITDA $935M vs. $869M last year
2d ago
Bausch Health downgraded to Hold from Buy at Jefferies
PremiumThe FlyBausch Health downgraded to Hold from Buy at Jefferies
15d ago
Bausch Health downgraded at Jefferies with B+L deal catalyst removed
Premium
The Fly
Bausch Health downgraded at Jefferies with B+L deal catalyst removed
15d ago
Bausch Health call volume above normal and directionally bullish
Premium
The Fly
Bausch Health call volume above normal and directionally bullish
15d ago
Bausch Health acknowledges XIFAXAN selection for Medicare Negotiation Program
PremiumThe FlyBausch Health acknowledges XIFAXAN selection for Medicare Negotiation Program
1M ago
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
Premium
The Fly
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
1M ago
Bausch Health, George Medicines sign exclusive licensing agreement or GMRx2
Premium
The Fly
Bausch Health, George Medicines sign exclusive licensing agreement or GMRx2
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100